Real-World Use and Outcome of Ropeginterferon ALFA-2B in Polycythemia VERA Patients: A Multicenteric Study

被引：0
|
作者：
Pugliese, Novella [1 ,2 ]
Di Perna, Maria [3 ]
De Martino, Ugo [1 ,2 ]
Amico, Valeria [4 ]
Annunziata, Mario [5 ,6 ]
Martorelli, Maria Carmen [7 ]
Abagnale, Davide Pio [1 ]
Russo, Roberta [1 ]
Ferrentino, Maria [1 ]
Scarpa, Alessia [1 ]
Muriano, Francesco [1 ]
Martinelli, Vincenzo [1 ]
Pane, Fabrizio [1 ]
机构：
[1] Univ Naples Federico II, Div Hematol, Naples, Italy
[2] Univ Naples Federico II, SCT Unit, Naples, Italy
[3] A Tortora Hosp, Onco Hematol Unit, Pagani, Italy
[4] Immunoematol & Trasfus Azienda Ospedaliera San Pio, Benevento, Italy
[5] AORN Cardarelli, Div Hematol, Naples, Italy
[6] Cardarelli Hosp, Hematol Unit, Naples, Italy
[7] Univ Hosp San Giovanni Dio & Ruggi Aragona, Hematol & Transplant Ctr, Salerno, Italy
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-210785
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6651 / 6651
页数：1
相关论文
共 50 条
  • [1] Ropeginterferon alfa-2b for the treatment of patients with polycythemia vera
    Wagner, S. M.
    Melchardt, I
    Greil, R.
    DRUGS OF TODAY, 2020, 56 (03) : 195 - 202
  • [2] Mechanism of Action of Ropeginterferon Alfa-2b in Polycythemia Vera Treatment
    Qin, Albert
    CLINICAL THERAPEUTICS, 2024, 46 (05) : 439 - 440
  • [3] Effective Management of Polycythemia Vera With Ropeginterferon Alfa-2b Treatment
    Suo, Shan Shan
    Fu, Rong Feng
    Qin, Albert
    Shao, Zong Hong
    Bai, Jie
    Chen, Su Ning
    Duan, Ming Hui
    Zhou, Hu
    Xu, Na
    Zhang, Su Jiang
    Zuo, Xue Lan
    Du, Xin
    Wang, Li
    Li, Pei
    Zhang, Xu Han
    Wu, Dao Xiang
    Li, Ya Ning
    Zhang, Jing Jing
    Wang, Wei
    Shen, Wei Hong
    Zagrijtschuk, Oleh
    Sato, Toshiaki
    Xiao, Zhi Jian
    Jin, Jie
    JOURNAL OF HEMATOLOGY, 2024, 13 (1-2) : 12 - 22
  • [4] 5 years of ropeginterferon alfa-2b in the treatment of polycythemia vera
    不详
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2024, 51 (06)
  • [5] A pharmacokinetic evaluation of ropeginterferon alfa-2b in the treatment of polycythemia vera
    Illes, Arpad
    Pinczes, Laszlo Imre
    Egyed, Miklos
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2021, 17 (01) : 3 - 7
  • [6] Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera
    Krecak, Ivan
    Skelin, Marko
    Verstovsek, Srdan
    EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (05) : 305 - 316
  • [7] A Case Report of Ropeginterferon Alfa-2b for Polycythemia Vera during Pregnancy
    Bang, Su-Yeon
    Lee, Sung-Eun
    HEMATOLOGY REPORTS, 2023, 15 (01) : 172 - 179
  • [8] Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b
    Jean-Jacques Kiladjian
    Christoph Klade
    Pencho Georgiev
    Dorota Krochmalczyk
    Liana Gercheva-Kyuchukova
    Miklos Egyed
    Petr Dulicek
    Arpad Illes
    Halyna Pylypenko
    Lylia Sivcheva
    Jiří Mayer
    Vera Yablokova
    Kurt Krejcy
    Victoria Empson
    Hans C. Hasselbalch
    Robert Kralovics
    Heinz Gisslinger
    Leukemia, 2022, 36 : 1408 - 1411
  • [9] Refining Symptom Response Criteria in Polycythemia Vera Patients Treated with Ropeginterferon Alfa-2b
    Lee, Sung-Eun
    Yoon, Sung-Soo
    Yang, Deok-Hwan
    Lee, Gyeong Won
    Yoon, Seug Yun
    Sohn, Sang Kyun
    Shin, Ho-Jin
    Bae, Sung Hwa
    Choi, Chul Won
    Choi, Eun-Ji
    Cheong, June-won
    Bang, Soo-Mee
    Park, Joon Seong
    Oh, Sukjoong
    Park, Yong
    Park, Young Hoon
    BLOOD, 2024, 144 : 6642 - 6643
  • [10] Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b
    Kiladjian, Jean-Jacques
    Klade, Christoph
    Georgiev, Pencho
    Krochmalczyk, Dorota
    Gercheva-Kyuchukova, Liana
    Egyed, Miklos
    Dulicek, Petr
    Illes, Arpad
    Pylypenko, Halyna
    Sivcheva, Lylia
    Mayer, Jiri
    Yablokova, Vera
    Krejcy, Kurt
    Empson, Victoria
    Hasselbalch, Hans C.
    Kralovics, Robert
    Gisslinger, Heinz
    LEUKEMIA, 2022, 36 (05) : 1408 - 1411
12345